SCHEMBL4680827

SCHEMBL4680827

O=CC=Cc1ccc(OCC(=O)O)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.53
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
ALDH1A1 P00352 4/20 0.50
FFAR1 O14842 2/20 0.49
PPARA Q07869 2/20 0.49
PPARG P37231 1/20 0.49
PPARD Q03181 1/20 0.49
GPR35 Q9HC97 2/20 0.49
PTPN7 P35236 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.49
MAPT P10636 2/20 0.48
KDM4E B2RXH2 1/20 0.48
PTPN12 Q05209 1/20 0.47
NPC1 O15118 1/20 0.47
POLB P06746 1/20 0.47
RAB9A P51151 1/20 0.47
BLM P54132 1/20 0.47
TRPA1 O75762 1/20 0.47
LMNA P02545 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4680821 1.00 ALOX15 (0.53) ALOX15MEN1KMT2AALDH1A1FFAR1
SCHEMBL20024689 0.87 ALOX15 (0.63) ALOX15MEN1KMT2AALDH1A1FFAR1
SCHEMBL6697095 0.82 ALOX15 (0.68) ALOX15MEN1KMT2AALDH1A1FFAR1
SCHEMBL6697101 0.82 ALOX15 (0.68) ALOX15MEN1KMT2AALDH1A1FFAR1
SCHEMBL349060 0.82 ALOX15 (0.61) ALOX15MEN1KMT2AALDH1A1FFAR1
SCHEMBL20024695 0.81 ALOX15 (0.52) ALOX15MEN1KMT2AALDH1A1FFAR1
SCHEMBL4683688 0.81 CCNB2 (0.65) ALOX15ALDH1A1PPARAPPARGPTPN7
SCHEMBL4683690 0.81 CCNB2 (0.65) ALOX15ALDH1A1PPARAPPARGPTPN7
SCHEMBL20024742 0.81 ALOX15 (0.55) ALOX15MEN1KMT2AALDH1A1FFAR1
SCHEMBL14314453 0.81 POLB (0.59) ALOX15MEN1KMT2AALDH1A1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1386913-B1 PYRROLE DERIVATIVE DAINIPPON SUMITOMO PHARMA CO (JP) 2008-07-16 EP disclosed
US-7220773-B2 Heterocylic amines used as antidiabetic or hyperglycemic agents DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2007-05-22 US disclosed
US-20040162331-A1 Pyrrole derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2004-08-19 US disclosed
EP-1386913-A1 PYRROLE DERIVATIVE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162331-A1 Pyrrole derivative SLC5A1, GLP1R, SLC5A2 ALOX15 2776/4885MEN1 3286/4885KMT2A 2866/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.